Trial Profile
Impact of Acthar on Proteinuria and Disease Progression in IgA Nephropathy Patients With Nephrotic Range Proteinuria
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Nephrotic syndrome
- Focus Therapeutic Use
- 03 Apr 2017 Status changed from recruiting to withdrawn prior to enrolment.
- 16 Mar 2015 New trial record